Author(s): Paolo Strati, Guillermo Garcia-Manero, Tapan Kadia, et al. Abstract: PS1251 Session topic: 10. Myelodysplastic syndromes – Clinical Background: Younger patients with high risk MDS are commonly treated with IC or enrolled in clinical trials investigating IC. The AZA-001 trial has shown a survival advantage for patients with high-risk MDS treated with...
Pro zobrazení tohoto obsahu je třeba být přihlášen.